A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Sublingual Zolpidem Tartrate Lozenge in Adult Patients With Insomnia Characterized by Difficulty Returning to Sleep After Middle-of-the-Night (MOTN) Awakening.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Sublingual Zolpidem Tartrate Lozenge in Adult Patients With Insomnia Characterized by Difficulty Returning to Sleep After Middle-of-the-Night (MOTN) Awakening.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jan 2012

At a glance

  • Drugs Zolpidem (Primary)
  • Indications Sleep maintenance insomnia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 19 Nov 2010 Results presented at the 10th International Forum on Mood and Anxiety Disorders.
    • 02 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
    • 10 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top